Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Medical Net

メディカルネット

3645 · TSE · Information & Communication · 1 article

Financials Consolidated

Revenue¥6.73bn+10.8% year on yearConsolidated · FY5/26

Ordinary profit¥270m+99.8% year on yearConsolidated · FY5/26

Net profit¥137mConsolidated · FY5/26

Dividend per share¥3.00FY5/26

Performance over time

Revenue
¥3.75bnFY5/22
¥4.50bnFY5/23
¥5.25bnFY5/24
¥6.08bnFY5/25
¥6.73bnFY5/26
Ordinary profit
¥450mFY5/22
¥432mFY5/23
¥323mFY5/24
¥135mFY5/25
¥270mFY5/26
Net profit (attributable)
¥380mFY5/22
¥116mFY5/23
¥5.96mFY5/24
−¥68.1mFY5/25
¥137mFY5/26
Op. cash flow
¥343mFY5/22
¥429mFY5/23
¥120mFY5/24
−¥80.9mFY5/25
¥98.8mFY5/26

People & pay

Employees, whole group290 peopleFY5/26

Employees, parent company (non-consolidated)135 peopleFY5/26

Average salary¥5.32mFY5/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY5/26¥6.73bn+10.8% year on year¥270m¥137.50m¥14.96¥3.00¥4.57bn¥2.07bn¥98.8m
FY5/25¥6.08bn+15.7% year on year¥135m−¥68.15m−¥7.64¥3.00¥4.08bn¥1.77bn−¥80.9m
FY5/24¥5.25bn+16.7% year on year¥323m¥5.96m¥0.66¥3.00¥3.99bn¥1.93bn¥119.6m
FY5/23¥4.50bn+20.2% year on year¥432m¥116.18m¥12.97¥2.50¥3.47bn¥1.93bn¥429.1m
FY5/22¥3.75bn¥450m¥380.10m¥43.44¥4.00¥3.15bn¥1.73bn¥342.6m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YYS4 · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:3645

Tokyo Brief coverage

  1. G-Medical Net enters supervised review while its Standard market move is assessed

    The company said it could not confirm compliance with the Growth market's market-capitalisation maintenance standard by the end of its improvement period, so the stock will be designated under review from June 1. Trading is set to continue while Tokyo Stock Exchange assesses its application to move to the Standard market, which the company says it meets on its own calculations.

All articles loaded · 1 shown

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

6 fiscal years · data through

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 May 2026No listed strategic holdings reported————Filed 
Show 5 more fiscal years (6 total)
Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 May 2025No listed strategic holdings reported————Filed 
31 May 2024No listed strategic holdings reported————Filed 
31 May 2023No listed strategic holdings reported————Filed 
31 May 2022No listed strategic holdings reported————Filed 
31 May 2021No listed strategic holdings reported————Filed